色多多下载官方版_色多多app最新版下载_色多多深夜福利免费观看_色多多网站入口官方版下载

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
The new medical insurance directory that 38 varieties is products also include star limited at the local level
 
Author:中國銘鉉 企劃部  Release Time:2017-2-28 8:49:51  Number Browse:693
 
Medical network - on February 27, the new medical insurance directory of adjustment finally in the long-awaited onstage. 1.5 trillion medical market, will enter another round of depth reconstruction period. Last time due to the medical insurance directory adjustment start market refactoring is 2009. 
 
Recently, people club department website announced the 2017 version of the health care medicine directory, the national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (2017 edition) "(hereinafter referred to as the catalog of medicines). This adjustment, the industry calls for many years. 
 
Part, "proprietary Chinese medicine supplemented many drug companies have become a big winner." A long-term focus on pharmaceutical sales person told the economic observer said network analysis. 
 
Compared with the 2009 edition, the latest version of the medical insurance directory increase 363 varieties, among them, the class a drugs increased 53 western medicine varieties, proprietary Chinese medicine adding 38 species. National medicine increased by 43 varieties. 
 
In expanded in scale, traditional Chinese medicine (TCM) expansion rate is bigger, more than 25%, especially national medicine Numbers have nearly doubled; Western medicine expansion rate of 11.43%. Adjustment for the new directory new variety, a number of medicine that compared to the expected industry assumptions and projections, middle medicine into the number more than western medicine. 
 
Last September 30, people club department released about 2016 national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue work adjustment plan (draft) ", the new medical insurance directory to adjust the overall requirements, proposed high clinical value of new drug, local b adjustment to increase more drugs, major disease treatment, children's drugs, urgent rescue medicine, occupational medicine will be transferred to the key, special focus more on transfer into the clinical value of drug and clinical basis. 
 
The half-year, conjecture about the health insurance directory management has never stopped, in the second half of last year, especially some biological medicine pharmaceutical enterprise, is also affected by the policy of positive factors, investors continue to look good. 
 
Obviously, the adjustment result, did not meet all expectations. 
 
A tour for those products with little surprise, hengrui pharmaceutical path for compaq heap, yasuhiro miyata pharmaceutical, did not enter the directory, biological medicine, in the adjustment has even been part of the personage inside course of study is called "running". 
 
However, this does not affect the stock market the positive evaluation of the news. 
 
News yesterday, 11 o 'clock, afternoon pharmaceutical sector will usher in a wave red, more than the rise, drugmakers more quickly. Stocks including billion sails pharmaceutical, evolution and kang pharmaceutical, happy people medicine, the sea is pharmaceutical related listed companies, because the new into the variety is more, there were different degree of increase, hundred million sails medicine, yi hundred pharmaceutical, sunflower pharmaceutical harden directly even a word. 
 
Chinese medicine led, the industry is also soon discover that the new directory for TCM injections using rules strictly restricted. The new directory in the remarks column, the traditional Chinese medicine injection, injection with proton pump inhibitors and antibiotics, the limitation of nutrition drugs present a trend of generalization, 49 Chinese medicine injection in 38 varieties by note limit severe, limit disease, also limits the use level of medical institutions, almost all varieties cannot be used at the grassroots level. 
 
This means that some larger sales of traditional Chinese medicine injection, such as injection with thrombus tong (lyophilization), toxic heat ning injection, phlegm heat injection, xi phlogistic flat injection of the dosage of the grass-roots hospitals and community hospitals will be restricted, unless the above Chinese herbal injection at the national or provincial supplemented base directory. For many mainly in the primary market of traditional Chinese medicine injection, such as injection with thrombus tong, sales or will fall sharply. 
 
Another piece of seemingly "cold" in view of the major workplace disease medication is still have a chance to enter the health care, that is last year start negotiation mechanism. For major workplace disease medication, countries will take each negotiation, enter the way to make it into the directory. In may last year, has been the treatment of tenofovir,, ek for three varieties through negotiations on medical insurance directory, by the government to negotiate with drug companies, the government give medicine into the health care increase sales opportunities, drug firms cut prices to ensure drug accessibility to increase, it is the first attempt at a time. 
 
This year after the new version of the directory, the subsequent new apt will also negotiate a way in the dynamic adjustment is into the directory, human resources and social security ministry put forward in the notice, to "explore establishing access to health care medicine negotiation mechanism. I will be determined via expert evaluation of negotiations negotiations drugs according to the rules, eligible drugs incorporated in the medical insurance to pay limits. The list shall be issued separately." Sources said, through expert review synchronous identified 45 to negotiate drug, are of higher clinical value but relatively expensive, exclusive patent drugs. The next step is to confirm whether enterprises have after negotiating intentions, publish to the society plans to negotiate drug list and group negotiation according to related procedure. 
 
The new directory, according to the medical insurance fund to pay a total of 2535 varieties, including western medicine, 1297, proprietary Chinese medicine 1238 (including ethnic medicine, 88). The fund of inductrial injury insurance granted only paid five varieties; Birth insurance fund granted only pay four varieties. Among them, the western medicine, 1297, proprietary Chinese medicine, 1238. 
 
In addition, people club department requirements, released in July 31 provinces local insurance of primary medical treatment, inductrial injury insurance and maternity insurance drug catalogue. Also requires to adjust the number of (including call in and out, adjust the limit to pay limits) shall not exceed 15% of the national class b drugs number, the provinces (autonomous regions and municipalities) b adjustment drugs dissolution set department for the record. People club department requirement, the provinces in the local drug release directory, after 1 month. 
 
Another level, along with the readjustment of health insurance directory, drug tender policy also in refactoring. Emphasized in the New Deal for expansion after the use of surveillance, proposed to establish and improve the medical service intelligent monitoring system of insurance of primary medical treatment monitoring analysis of drug use and social insurance system, the key monitoring dosage, expense and there may be more not rational use of medicines, monitoring results to the public in the proper manner. This is to control health care costs of the trend of The Times, also means that the control of drugs is very difficult to appear like version released in 2009 after the explosion. 
 
Previous article:State drug safety administration said: 138 clinical big varieties should be checked!
Next article:44 companies drugs new medical insurance directory Part of the product sales is over
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網(wǎng)安備 44011202000029號